Correlation Between Apellis Pharmaceuticals and Ocean Biomedical
Can any of the company-specific risk be diversified away by investing in both Apellis Pharmaceuticals and Ocean Biomedical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Apellis Pharmaceuticals and Ocean Biomedical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Apellis Pharmaceuticals and Ocean Biomedical, you can compare the effects of market volatilities on Apellis Pharmaceuticals and Ocean Biomedical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apellis Pharmaceuticals with a short position of Ocean Biomedical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apellis Pharmaceuticals and Ocean Biomedical.
Diversification Opportunities for Apellis Pharmaceuticals and Ocean Biomedical
0.52 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Apellis and Ocean is 0.52. Overlapping area represents the amount of risk that can be diversified away by holding Apellis Pharmaceuticals and Ocean Biomedical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ocean Biomedical and Apellis Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apellis Pharmaceuticals are associated (or correlated) with Ocean Biomedical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ocean Biomedical has no effect on the direction of Apellis Pharmaceuticals i.e., Apellis Pharmaceuticals and Ocean Biomedical go up and down completely randomly.
Pair Corralation between Apellis Pharmaceuticals and Ocean Biomedical
Given the investment horizon of 90 days Apellis Pharmaceuticals is expected to generate 1.16 times more return on investment than Ocean Biomedical. However, Apellis Pharmaceuticals is 1.16 times more volatile than Ocean Biomedical. It trades about 0.15 of its potential returns per unit of risk. Ocean Biomedical is currently generating about -0.3 per unit of risk. If you would invest 2,734 in Apellis Pharmaceuticals on August 27, 2024 and sell it today you would earn a total of 343.00 from holding Apellis Pharmaceuticals or generate 12.55% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Apellis Pharmaceuticals vs. Ocean Biomedical
Performance |
| Timeline |
| Apellis Pharmaceuticals |
| Ocean Biomedical |
Apellis Pharmaceuticals and Ocean Biomedical Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Apellis Pharmaceuticals and Ocean Biomedical
The main advantage of trading using opposite Apellis Pharmaceuticals and Ocean Biomedical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apellis Pharmaceuticals position performs unexpectedly, Ocean Biomedical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ocean Biomedical will offset losses from the drop in Ocean Biomedical's long position.| Apellis Pharmaceuticals vs. Eliem Therapeutics | Apellis Pharmaceuticals vs. HCW Biologics | Apellis Pharmaceuticals vs. Scpharmaceuticals | Apellis Pharmaceuticals vs. Milestone Pharmaceuticals |
| Ocean Biomedical vs. Enveric Biosciences | Ocean Biomedical vs. Hepion Pharmaceuticals | Ocean Biomedical vs. Elevation Oncology | Ocean Biomedical vs. Zura Bio Limited |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Complementary Tools
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |